$Heart Test Laboratories(HSCS.US)$Heartsciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-Ecg
$Heart Test Laboratories(HSCS.US)$• Further clinical validation of MyoVista technology from a peer-reviewed publication with data demonstrating that screening for heart disease in diabetic patients using a MyoVista AI-ECG model significantly outperformed conventional screening standards of care. Diabetes represents a major risk factor for heart disease and affects approximately 500 million people worldwide; • Significantly improved financial position. The Q3 FY2024 sharehol...
Heart Test Laboratories股票討論區
• Significantly improved financial position. The Q3 FY2024 sharehol...
暫無評論